A Microport Neuro announcement expects first-half revenue to reach 400 million to 410 million yuan, an increase of about 34% to 37% year-on-year. Revenue growth is mainly attributed to breakthroughs in overseas business, with revenue expected to increase by about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; spring coil products benefiting from winning centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.
Ver original
Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.
MicroBrain Science: Prevê-se um aumento da receita de cerca de 34% a 37% em relação ao mesmo período do ano anterior
A Microport Neuro announcement expects first-half revenue to reach 400 million to 410 million yuan, an increase of about 34% to 37% year-on-year. Revenue growth is mainly attributed to breakthroughs in overseas business, with revenue expected to increase by about 70% to 90%; an increase in market share of intracranial atherosclerotic stenosis products; spring coil products benefiting from winning centralized procurement bids, accelerating the development of blank markets; and the accelerated hospital access and clinical use of multiple acute ischemic stroke and pathway products.